EBNA IgG (Epstein-Barr Nuclear Antigen) Antibody Biomarker Testing
It shows prior Epstein-Barr exposure and helps interpret EBV timing; order through Vitals Vault for Quest-based labs with PocketMD guidance.
With Vitals Vault, you have access to a comprehensive range of biomarker tests.
EBNA IgG is one of the most commonly misunderstood Epstein-Barr virus (EBV) antibody results. If you see “positive” on a report, it often reflects a past infection rather than an active illness.
This test becomes most useful when you are trying to place EBV on a timeline—especially if you have fatigue, a recent “mono” (infectious mononucleosis) concern, or you are wondering whether EBV explains current symptoms.
EBNA IgG is rarely interpreted alone. Your clearest answer usually comes from looking at EBNA IgG together with other EBV antibodies and your clinical story, because antibodies can stay detectable for years.
Do I need a Epstein Barr Virus Nuclear Antigen EBNA Antibody IgG test?
You may want an EBNA IgG test if you are trying to understand whether you have had EBV in the past, especially after a period of prolonged fatigue, swollen lymph nodes, sore throat, or a mono-like illness. It can also be helpful if you were told you had EBV before and you want to confirm prior exposure.
This test is also commonly ordered when your clinician is sorting out whether symptoms are more consistent with a recent EBV infection versus something else. EBNA IgG tends to appear later after infection, so it can help distinguish “recent/acute” patterns from “past infection” patterns when paired with other EBV markers.
You may not need EBNA IgG if your only goal is to explain chronic fatigue on its own. Many people have positive EBV IgG antibodies from earlier in life, and that finding alone does not prove EBV is the cause of current symptoms.
Testing can support clinician-directed care and return-to-activity decisions, but it is not a standalone diagnosis of EBV reactivation or the reason for fatigue without the rest of your evaluation.
This is a blood antibody (serology) test typically performed in a CLIA-certified laboratory; results should be interpreted with symptoms, timing, and companion EBV markers rather than used as a stand-alone diagnosis.
Lab testing
Order labs to measure Epstein-Barr Virus Nuclear Antigen (EBNA) Antibody (IgG)
from $185.20 at Quest Diagnostics
About 1 week
Schedule online — results typically within a week
Clear next steps
Guidance included, with follow-up care available
HSA / FSA
Eligible for pre-tax health spending accounts
Get this test with Vitals Vault
If you are trying to make sense of an EBV history or a mono-like illness, Vitals Vault lets you order EBV-related labs without needing to coordinate multiple appointments. You can choose a focused EBV antibody option or a broader panel when your symptoms overlap with other causes of fatigue.
After your results are in, PocketMD can help you translate antibody patterns into plain language questions to bring to your clinician—such as whether your pattern fits prior exposure, a recent infection window, or an indeterminate result that needs repeat testing.
If you are tracking symptoms over time, you can also use Vitals Vault to repeat testing in a consistent way, which is often more informative than a single snapshot.
- Order online and complete testing through a national lab network
- PocketMD helps you prepare next-step questions based on your pattern
- Designed for trending results over time when follow-up is appropriate
Key benefits of Epstein Barr Virus Nuclear Antigen EBNA Antibody IgG testing
- Helps confirm whether you have had EBV in the past, even if you do not remember being sick.
- Adds timing context when combined with EBV VCA IgM and VCA IgG results.
- Can help clarify confusing “positive EBV antibodies” reports that are often misread as active infection.
- Supports more informed return-to-activity conversations after a mono-like illness when interpreted with your symptoms and exam.
- Reduces unnecessary repeat testing by showing a stable past-infection marker in many people.
- Helps your clinician decide whether additional EBV testing (such as early antigen) or non-EBV causes of fatigue should be prioritized.
- Gives you a baseline result you can trend if follow-up serology is recommended.
What is Epstein Barr Virus Nuclear Antigen EBNA Antibody IgG?
EBV is a very common virus in the herpesvirus family. After infection, your immune system makes antibodies to different EBV proteins at different times. EBNA stands for Epstein-Barr virus nuclear antigen, a protein expressed later in the infection cycle.
EBNA IgG is an immunoglobulin G (IgG) antibody your body produces against EBNA. In many people, EBNA IgG becomes detectable weeks to months after the initial infection and then remains positive for years, often for life.
Because EBNA IgG is usually a “later” antibody, it is often used to help distinguish a past infection pattern from an early/acute infection pattern. However, it does not tell you by itself whether EBV is currently active in your body or whether EBV is the cause of current symptoms.
How EBNA IgG fits into an EBV antibody pattern
EBV serology is typically interpreted as a pattern across multiple antibodies. A common approach is to look at VCA IgM (often rises early), VCA IgG (rises and persists), and EBNA IgG (often appears later). Your clinician may also use EBV early antigen (EA) antibodies in select situations, but EA results can be harder to interpret and are not definitive on their own.
What EBNA IgG cannot prove
A positive EBNA IgG does not automatically mean “reactivation,” “chronic EBV,” or that you are contagious. It mainly indicates immune memory of prior exposure. If you are dealing with persistent symptoms, the next step is usually to evaluate other causes (sleep, iron status, thyroid function, inflammation, mood, medications, and more) while using EBV labs only as one piece of the picture.
What do my Epstein Barr Virus Nuclear Antigen EBNA Antibody IgG results mean?
Low or negative EBNA IgG
A low or negative EBNA IgG often means you have not had EBV before, or that it is too early in the course of a new infection for EBNA IgG to appear. If you have mono-like symptoms and EBNA IgG is negative, your clinician will usually look closely at VCA IgM and VCA IgG, and may recommend repeat testing after a few weeks if timing is unclear. In people with weakened immune systems, antibody responses can be blunted, which can also lead to negative results despite infection.
In-range or expected EBNA IgG pattern
For most labs, EBNA IgG is reported as negative/positive (or an index value) rather than an “optimal” numeric range. An “expected” pattern depends on why you tested. If your goal is to confirm past exposure, a positive EBNA IgG together with positive VCA IgG and negative VCA IgM commonly supports prior infection rather than a new acute infection. If your goal is to evaluate current symptoms, an expected past-infection pattern may simply mean EBV is part of your history, not necessarily your current driver.
High or strongly positive EBNA IgG
A high or strongly positive EBNA IgG typically still points to past infection, because IgG levels can remain elevated long-term. Higher numbers do not reliably correlate with symptom severity, contagiousness, or “how active” EBV is. If you are worried about reactivation, your clinician may consider the full EBV panel pattern, your physical exam, and sometimes other tests, rather than using EBNA IgG magnitude alone.
Factors that influence EBNA IgG results
Timing is the biggest factor: EBNA IgG often becomes positive later than other EBV antibodies, so early testing can look negative even if EBV is the cause. Immune status matters as well—immunosuppression can reduce antibody production and make patterns harder to interpret. Different labs use different assays and cutoffs, so “equivocal” results may need repeat testing at the same lab for clarity. Finally, EBV antibodies are common in the general population, so your pre-test likelihood (your symptoms and exposure history) strongly affects what a positive result means for you.
What’s included
- Ebv Nuclear Ag (Ebna) Ab (Igg)
Similar tests you may want to consider
Frequently Asked Questions
Does a positive EBNA IgG mean I have an active EBV infection?
Usually not. EBNA IgG most often indicates past EBV exposure because it tends to appear later after infection and can stay positive for years. To evaluate a possible current or recent infection, EBNA IgG needs to be interpreted with VCA IgM, VCA IgG, your symptom timing, and your exam.
Can EBNA IgG tell me if EBV is “reactivated”?
EBNA IgG alone cannot confirm reactivation. Many people with no EBV-related symptoms have positive EBNA IgG. If reactivation is a concern, your clinician may review the full EBV serology pattern and consider other tests based on your situation, rather than relying on EBNA IgG level.
What is the difference between EBNA IgG and VCA IgG?
Both are IgG antibodies to EBV, but they target different viral proteins and often appear at different times. VCA IgG typically becomes positive during or soon after infection and persists, while EBNA IgG often becomes positive later. Looking at both helps place EBV on a timeline.
If my EBNA IgG is negative, can I still have mono?
Yes. Early in a new EBV infection, EBNA IgG may still be negative. In that setting, VCA IgM and VCA IgG patterns (and sometimes repeat testing) are more informative for timing.
Do I need to fast for an EBNA IgG blood test?
Fasting is not usually required for EBV antibody testing. If your blood draw includes other tests that do require fasting (such as lipids), follow the instructions for the full set of labs you ordered.
How long does EBNA IgG stay positive?
In many people, EBNA IgG remains positive long-term, often for life. That is why a positive result is commonly interpreted as evidence of prior infection rather than something new.
Can EBV antibodies explain chronic fatigue by themselves?
Not reliably. Because EBV IgG antibodies are common, a positive EBNA IgG does not prove EBV is the cause of fatigue. If you have persistent fatigue, it is usually worth evaluating other common contributors while using EBV serology as only one part of the overall assessment.